These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31406127)

  • 21. TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype.
    Sagnelli C; Merli M; Uberti-Foppa C; Hasson H; Grandone A; Cirillo G; Salpietro S; Minichini C; Starace M; Messina E; Morelli P; Miraglia Del Giudice E; Lazzarin A; Coppola N; Sagnelli E
    World J Gastroenterol; 2016 Oct; 22(38):8509-8518. PubMed ID: 27784963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Genetics of Clinical Liver Diseases: Insight into the
    Zhang X; Liu S; Dong Q; Xin Y; Xuan S
    J Clin Transl Hepatol; 2018 Sep; 6(3):326-331. PubMed ID: 30271746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basic and translational evidence supporting the role of TM6SF2 in VLDL metabolism.
    Liu J; Ginsberg HN; Reyes-Soffer G
    Curr Opin Lipidol; 2024 Jun; 35(3):157-161. PubMed ID: 38465912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of Caloric Intake Might Override the Prosteatotic Effects of the PNPLA3 p.I148M and TM6SF2 p.E167K Variants in Patients with Fatty Liver: Ultrasound-Based Prospective Study.
    Krawczyk M; Stachowska E; Milkiewicz P; Lammert F; Milkiewicz M
    Digestion; 2016; 93(2):139-48. PubMed ID: 26745555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human Multilineage 3D Spheroids as a Model of Liver Steatosis and Fibrosis.
    Pingitore P; Sasidharan K; Ekstrand M; Prill S; Lindén D; Romeo S
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30986904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paradoxical dissociation between hepatic fat content and de novo lipogenesis due to PNPLA3 sequence variant.
    Mancina RM; Matikainen N; Maglio C; Söderlund S; Lundbom N; Hakkarainen A; Rametta R; Mozzi E; Fargion S; Valenti L; Romeo S; Taskinen MR; Borén J
    J Clin Endocrinol Metab; 2015 May; 100(5):E821-5. PubMed ID: 25763607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients.
    Milano M; Aghemo A; Mancina RM; Fischer J; Dongiovanni P; De Nicola S; Fracanzani AL; D'Ambrosio R; Maggioni M; De Francesco R; Fargion S; Berg T; Stickel F; Hampe J; Romeo S; Colombo M; Valenti L
    Hepatology; 2015 Jul; 62(1):111-7. PubMed ID: 25820484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models.
    Longo M; Meroni M; Paolini E; Erconi V; Carli F; Fortunato F; Ronchi D; Piciotti R; Sabatini S; Macchi C; Alisi A; Miele L; Soardo G; Comi GP; Valenti L; Ruscica M; Fracanzani AL; Gastaldelli A; Dongiovanni P
    Cell Mol Gastroenterol Hepatol; 2022; 13(3):759-788. PubMed ID: 34823063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease.
    Kozlitina J; Smagris E; Stender S; Nordestgaard BG; Zhou HH; Tybjærg-Hansen A; Vogt TF; Hobbs HH; Cohen JC
    Nat Genet; 2014 Apr; 46(4):352-6. PubMed ID: 24531328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The dual and opposite role of the TM6SF2-rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: A meta-analysis.
    Pirola CJ; Sookoian S
    Hepatology; 2015 Dec; 62(6):1742-56. PubMed ID: 26331730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver-Specific Deletion of Mouse Tm6sf2 Promotes Steatosis, Fibrosis, and Hepatocellular Cancer.
    Newberry EP; Hall Z; Xie Y; Molitor EA; Bayguinov PO; Strout GW; Fitzpatrick JAJ; Brunt EM; Griffin JL; Davidson NO
    Hepatology; 2021 Sep; 74(3):1203-1219. PubMed ID: 33638902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic Determinants of Circulating Lipoproteins in Nonalcoholic Fatty Liver Disease.
    Jiang ZG; Tapper EB; Kim M; Connelly MA; Krawczyk SA; Yee EU; Herman MA; Mukamal KJ; Lai M
    J Clin Gastroenterol; 2018; 52(5):444-451. PubMed ID: 28362682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inactivation of Tm6sf2, a Gene Defective in Fatty Liver Disease, Impairs Lipidation but Not Secretion of Very Low Density Lipoproteins.
    Smagris E; Gilyard S; BasuRay S; Cohen JC; Hobbs HH
    J Biol Chem; 2016 May; 291(20):10659-76. PubMed ID: 27013658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type 2 diabetes sex-specific effects associated with E167K coding variant in
    Fan Y; Wolford BN; Lu H; Liang W; Sun J; Zhou W; Rom O; Mahajan A; Surakka I; Graham SE; Liu Z; Kim H; Ramdas S; Fritsche LG; Nielsen JB; Gabrielsen ME; Hveem K; Yang D; Song J; Garcia-Barrio MT; Zhang J; Liu W; Zhang K; Willer CJ; Chen YE
    iScience; 2021 Nov; 24(11):103196. PubMed ID: 34746691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TM6SF2: A Novel Genetic Player in Nonalcoholic Fatty Liver and Cardiovascular Disease.
    Luo F; Oldoni F; Das A
    Hepatol Commun; 2022 Mar; 6(3):448-460. PubMed ID: 34532996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Construction of transmembrane 6 superfamily member 2 E167K gene knock-in mouse model by using CRISPR/Cas9 technology].
    Sun BK; Liu SS; Zhang J; Xuan SY; Xin YN
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jul; 28(7):591-596. PubMed ID: 32791795
    [No Abstract]   [Full Text] [Related]  

  • 37. PNPLA3 I148M variant affects non-alcoholic fatty liver disease in liver transplant recipients.
    Liu ZT; Chen TC; Lu XX; Cheng J; Xie HY; Zhou L; Zheng SS
    World J Gastroenterol; 2015 Sep; 21(34):10054-6. PubMed ID: 26379412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TM6SF2 Glu167Lys polymorphism is associated with low levels of LDL-cholesterol and increased liver injury in obese children.
    Grandone A; Cozzolino D; Marzuillo P; Cirillo G; Di Sessa A; Ruggiero L; Di Palma MR; Perrone L; Miraglia Del Giudice E
    Pediatr Obes; 2016 Apr; 11(2):115-9. PubMed ID: 25893821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population-based meta-analysis and gene-set enrichment identifies FXR/RXR pathway as common to fatty liver disease and serum lipids.
    Handelman SK; Puentes YM; Kuppa A; Chen Y; Du X; Feitosa MF; Palmer ND; Speliotes EK
    Hepatol Commun; 2022 Nov; 6(11):3120-3131. PubMed ID: 36098472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. E167K polymorphism of TM6SF2 gene affects cell cycle of hepatocellular carcinoma cell HEPA 1-6.
    Du S; Lu L; Miao Y; Jin W; Li C; Xin Y; Xuan S
    Lipids Health Dis; 2017 Apr; 16(1):76. PubMed ID: 28407767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.